Associated Papers
Identification of Targetable Recurrent MAP3K8 Rearrangements in Melanomas Lacking Known Driver Mutations.
Lehmann BD et al.
Molecular Cancer Research : Mcr, 2019
Stamping out RAF and MEK1/2 to inhibit the ERK1/2 pathway: an emerging threat to anticancer therapy.
Mandal R et al.
Oncogene, 2016
Phosphorylation of threonine 290 in the activation loop of Tpl2/Cot is necessary but not sufficient for kinase activity.
Luciano BS et al.
The Journal of Biological Chemistry, 2004
Select a paper to view details